Breast cancer has higher fatality rates in low-to-middle-income countries (LMICs) within Sub-Saharan Africa compared to more developed countries. Extensive wait times for an evaluation and lack of timely follow-up care contribute to this disparity. In LMICs, breast core needle biopsies (CNBs) are commonly taken from patients by palpation, then transferred to pathologists who manually chemically preserve, slice, and analyze the tissue, which may take weeks to months for a report. We are developing CoreView, a fast, automated, and low-cost device with the ability to assess disease status within one patient visit. The CoreView instrument accepts fresh CNBs, automatically stains tissue surfaces, and generates an optical diagnostic image. For nuclei to be imaged rapidly with high-resolution within a limited depth of focus, the CNB must be pressed against a smooth clear surface, which also maximizes the tissue surface area being analyzed. To do this, compression mechanisms were modeled in SolidWorks using a piston approach and fluidic pumps to apply positive pressure. Breast tissue has low stiffness, requiring precise, applied forces. The CNB integrity and diagnostic image quality during compression was quantitatively video monitored and studied. As a control, images of compressed porcine breast CNBs were compared to matched uncompressed tissues to determine any damage with compression, and measured improvement in diagnostic image quality. Breast CNBs are expected to withstand a maximum pressure of 1.5 psi without significant tissue deformity; however, the threshold depends on the prototype dimensions/geometry. The goal is to form high-magnification, panoramic diagnostic images along the entire length of 20 mm long CNBs with ~20x microscope objective lens within one minute using motorized stage and synchronized imaging. With a reliable design and precisely controlled compression process, CoreView allows for efficient, high-resolution tissue imaging and diagnostic analysis at the point of care, reducing health disparities through prompt breast cancer treatment.